Results of the ROAR basket study: the efficacy and safety of combined tumor-agnostic therpy in pacients with BRAFV6ooE-murated rare cancers

by VHIO

Encouraging efficacy and safety results of the phase II ROAR basket study support tumor-agnostic therapy in patients with rare cancers and suggest that genetic testing and tumor profiling should be in...

Read more

La administración de oligonucleótidos antisentido recupera la regeneración axonal en modelos de esclerosis lateral amiotrófica

by Revista Genética Médica

Han demostrado que el tratamiento con un fármaco de diseño que modifica el procesado del ARN puede ralentizar la neurodegeneración típica de la esclerosis lateral amiotrófica (ELA). Sus resultado...

Read more

Mineralys Therapeutics Announces First Patient Dosed in the ADVANCE-HTN Pivotal Trial of Lorundrostat for the Treatment of Uncontrolled and Resistant Hypertension

by Ysios Capital

Mineralys Therapeutics today announced the first patient dosed in the ADVANCE-HTN pivotal trial to evaluate the safety and efficacy of lorundrostat for the treatment of uncontrolled hypertension (uHTN...

Read more

Results from SUNLIGHT study point to practice-changing care for patients with refractory metastastic colorectal cancer

by VHIO

A phase III clinical trial comparing the efficacy the combination of Trifluridine/tipiracil plus the antibody bevacizumab versus Trifluridine/tipiracil in patients with refractory metastatic colonrect...

Read more

They improve the effect of an antitumor drug against pancreatic cancer by binding to a calcium phosphate nanoparticle

by Instituto de Investigación Biosanitaria - Ibs Granada

ibs.GRANADA researchers have developed calcium phosphate nanoparticles to transport antitumor drugs used in pancreatic cancer that improve their effect on this type of tumor

Read more

Atrys, pionera en la aplicación de un nuevo fármaco en cáncer de próstata en Portugal

by Atrys Health

Atrys Health, compañía global que presta servicios de prevención, diagnóstico y tratamiento médico de precisión y pionera en telemedicina y radioterapia de última generación, ha sido la primer...

Read more

Alta eficacia de un fármaco en leucemia linfoblástica aguda infantil asociada a mutaciones en el gen KMT2A

by Revista Genética Médica

El tratamiento con blinatumomab mejora notablemente la supervivencia en pacientes infantiles que acaban de ser diagnosticados con leucemia linfoblástica aguda asociada a reorganizaciones en el gen KM...

Read more

The power of three: triplet drug combination slows disease progression in patients with advanced kidney cancer

by VHIO

Results of the phase 3 COSMIC-313 trial show that the addition of targeted kinase inhibitor cabozantinib to dual checkpoint inhibition with nivolumab and ipilimumab in patients with advanced or metast...

Read more

Scientists identify how some angiogenic drugs used to treat cancer and heart disease cause vascular disease

by Centro Nacional de Investigaciones Cardiovasculares - CNIC

The new study, published in Nature Cardiovascular Research, will help to select the most effective and safe way to modulate angiogenesis in ischemic tissues or in cancer

Read more

A novel treatment combination shows promise as first-line treatment in patients with metastatic castration-resistant prostate cancer

by VHIO

Results from the Phase III TALAPRO-2 trial demonstrate that the combination of talazoparib plus enzalutamide vs. standard treatment of enzalutamide plus placebo significantly improves progression-free...

Read more

El Hospital 12 de Octubre participa en un ensayo clínico internacional que demuestra que una pastilla detiene varios años la progresión de un tumor cerebral maligno

by Hospital Universitario 12 de Octubre

El Hospital 12 de Octubre participa en un ensayo clínico internacional que demuestra que un inhibidor denominado vorasidenib, que se administra vía oral, detiene varios años la progresión de un ti...

Read more

VHIO on the groud of ASCO: Predictive biomarkers and the promise of new therapeutic opportunities in lung cancer

by VHIO

VHIO led and participated in a dozen studies on lung cancer that were presented at the American Society of Clinical Oncology (ASCO) meeting held June 2-6 in Chicago.

Read more
Subscribe to Directory
Write an Article

Recent News

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Un ensayo de microscopía dinámica del ...

by CSIC - Centro Superior de Investigaciones Científicas

La revista ‘Nature Protocols’ selecciona esta técnica como “pro...

Photos Stream